Marc de Garidel
Marc de Garidel is a French businessman.[1] He serves as the non-executive chairman of the pharmaceutical company Ipsen and advises Mayroy, the Ipsen controlling holding company.[1][2][3][4][5]
Biography
Early life
Marc de Garidel graduated from the École Spéciale des Travaux Publics, an engineering grandes écoles in Paris.[1][3][4] He received business degrees from the Thunderbird School of Global Management in Glendale, Arizona and the Harvard Business School.[1][3][4]
Career
In 1983, he started his career at Eli Lilly and Company, where he worked in France, the United States and Germany.[1][3]
In 1995, he joined Amgen as Vice President, of Finance and Treasury for Europe.[1][3][4] In 1998, he became Vice President, Corporate Controller and Chief Accounting Officer of Amgen.[1][3] In 2000, he became Vice President and General Manager for France, in charge of Amgen France.[1][3] In 2006, he became Vice President for Southwestern Europe, including France, Spain, Belgium and Portugal.[1][3] From 2007 to 2010, he served as Vice President for Southern Europe, the Middle East, Asia and Latin America at Amgen.[1][3][4]
He has served as Chairman and CEO of Ipsen since November 2010.[1][3][4][5] He sits on the Board of Directors of TcLand Expression.[1] He is also Chairman of the Board of Promethera Biosciences and European Biopharmaceutical Entreprises.[1][4]
He is President and spokesperson for G5 santé, a lobbying group for French pharmaceutical companies, including BioMérieux, Guerbet, Ipsen, the Laboratoire français du Fractionnement et des Biotechnologies, Laboratoires Pierre Fabre, Sanofi, Stallergenes and Laboratoires Théa.[5]
The Board of Directors of Ipsen has appointed David Meek as Chief Executive Officer, effective July 18, 2016.[2] On this date, Marc de Garidel will assume the role of non-executive chairman and will continue to serve the Board of Directors through his deep industry expertise. In addition, Marc de Garidel will advise Mayroy, the Ipsen controlling holding company.[6]
He is a Knight in the National Order of the Legion of Honour.
Bibliography
- La Société du Médicament (2006)
References
- ^ a b c d e f g h i j k l m "Marc M.P. de Garidel: Executive Profile & Biography". Bloomberg. Retrieved 4 November 2016.
- ^ a b "(David Meek new CEO of Ipsen)" (PDF). Archived from the original (PDF) on 2016-09-23.
{{cite web}}: Unknown parameter|dead-url=ignored (|url-status=suggested) (help) Cite error: The named reference "David Meek appointed as Chief Executive Officer of Ipsen" was defined multiple times with different content (see the help page). - ^ a b c d e f g h i j "Ipsen biography". Archived from the original on 2013-04-11.
{{cite web}}: Unknown parameter|deadurl=ignored (|url-status=suggested) (help) - ^ a b c d e f g "Management". Promethera Biosciences. Board of Directors & and (sic) founders. Archived from the original on 11 October 2014.
{{cite web}}: Unknown parameter|dead-url=ignored (|url-status=suggested) (help) - ^ a b c "Les membres du G5 santé" [The G5 Health] (in French). G5 Health.
- ^ "David Meek appointed as Chief Executive Officer of Ipsen" (Press release). Ipsen. 11 July 2016 – via Business Wire.